Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kitano, Katsunori ^a   Usui, Soichiro ^a   Ootsuji, Hiroshi ^a   Takashima, Shin Ichiro ^a   Kobayashi, Daisuke ^a   Murai, Hisayoshi ^a   Furusho, Hiroshi ^a   Nomura, Ayano ^a   Kaneko, Shuichi ^a   Takamura, Masayuki ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FASUDIL; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; LEUKOCYTE; LEUKOPENIA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; APOPTOSIS; CYTOKINES; ENZYME ACTIVATION; INFLAMMATION MEDIATORS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84898648253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092242     Document Type: Article

References (38)

1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278: 2093-2098. (Pubitemid 28016233)
2. Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76: 1713-1719.
3. Prasad A, Stone GW, Holmes DR, Gersh B (2009) Reperfusion injury, microvascular dysfunction, and cardioprotection: the ''dark side'' of reperfusion. Circulation 120: 2105-2112.
4. Satoh K, Fukumoto Y, Shimokawa H (2011) Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 301: H287-296.
5. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, et al. (2002) Antianginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 40: 751-761. (Pubitemid 36109293)
6. Loirand G, Guerin P, Pacaud P (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98: 322-334.
7. Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, et al. (2001) Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sci 69: 1441-1453. (Pubitemid 32758711)
8. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106: 57-62. (Pubitemid 34747442)
9. Hamid SA, Bower HS, Baxter GF (2007) Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Am J Physiol Heart Circ Physiol 292: H2598-2606. (Pubitemid 47084509)
10. Dhingra S, Sharma AK, Arora RC, Slezak J, Singal PK (2009) IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 82: 59-66.
11. Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58: 88-111.
12. Kin H, Wang NP, Halkos ME, Kerendi F, Guyton RA, et al. (2006) Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/ TNFalpha release after ischemia and reperfusion. J Surg Res 135: 170-178. (Pubitemid 44215908)
13. Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, et al. (2008) Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 295: H1311-H1318.
14. Bao W, Hu E, Tao L, Boyce R, Mirabile R, et al. (2004) Inhibition of Rhokinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res 61: 548-558. (Pubitemid 38210160)
15. Nohria A, Grunert ME, Rikitake Y, Noma K, Prsic A, et al. (2006) Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 99: 1426-1432. (Pubitemid 44949679)
16. Ohtani K, Usui S, Kaneko S, Takashima S, Kitano K, et al. (2012) Benidipine reduces ischemia reperfusion-induced systemic oxidative stress through suppression of aldosterone production in mice. Hypertens Res 35: 287-294.
17. Odashima M, Usui S, Takagi H, Hong C, Liu J, et al. (2007) Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res 100: 1344-1352. (Pubitemid 46742925)
18. Baba T, Ishizu A, Iwasaki S, Suzuki A, Tomaru U, et al. (2006) CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/ macrophages with a cytotoxic phenotype. Blood 107: 2004-2012. (Pubitemid 43289384)
19. Coxon A, Tang T, Mayadas TN (1999) Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/ macrophage colony-stimulating factor. J Exp Med 190: 923-934.
20. Ootsuji H, Honda M, Kaneko S, Usui S, Okajima M, et al. (2010) Altered hepatic gene expression profiles associated with myocardial ischemia. Circ Cardiovasc Genet 3: 68-77.
21. Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, et al. (2009) Neutralization of interleukin-18 ameliorates ischemia/reperfusioninduced myocardial injury. J Biol Chem 284: 7853-7865.
22. Liu Y, Sun R, Lin X, Liang D, Deng Q, et al. (2012) Kaposi's sarcomaassociated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J Virol 86: 1372-1381.
23. Usui S, Maejima Y, Pain J, Hong C, Cho J, et al. (2011) Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB. Circ Res 109: 161-171.
24. Lawson CA, Yan SD, Yan SF, Liao H, Zhou YS, et al. (1997) Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 99: 1729-1738. (Pubitemid 27163825)
25. Vinten-Johansen J (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61: 481-497. (Pubitemid 38210154)
26. Hasan Z, Palani K, Rahman M, Zhang S, Syk I, et al. (2012) Rho-kinase signaling regulates pulmonary infiltration of neutrophils in abdominal sepsis via attenuation of CXC chemokine formation and Mac-1 expression on neutrophils. Shock 37: 282-288.
27. Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Tsoufis C, et al. (2007) Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. Int J Cardiol 115: 203-207. (Pubitemid 46136522)
28. Pfohl M, Schreiber I, Liebich HM, Haring HU, Hoffmeister HM (1999) Upregulation of cholesterol synthesis after acute myocardial infarction-is cholesterol a positive acute phase reactant? Atherosclerosis 142: 389-393.
29. Nakayama M, Kudoh T, Kaikita K, Yoshimura M, Oshima S, et al. (2008) Class A macrophage scavenger receptor gene expression levels in peripheral blood mononuclear cells specifically increase in patients with acute coronary syndrome. Atherosclerosis 198: 426-433. (Pubitemid 351707380)
30. Kikuchi Y, Yasuda S, Aizawa K, Tsuburaya R, Ito Y, et al. (2011) Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment. J Am Coll Cardiol 58: 1231-1237.
31. Feske SK, Sorond FA, Henderson GV, Seto M, Hitomi A, et al. (2009) Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res 1257: 89-93.
32. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, et al. (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016-1023. (Pubitemid 13080480)
33. Fliss H, Gattinger D (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956. (Pubitemid 26359236)
34. Okamoto R, Li Y, Noma K, Hiroi Y, Liu PY, et al. (2013) FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2. FASEB J 27: 1439-1449.
35. Bolger AP, Sharma R, von Haehling S, Doehner W, Oliver B, et al. (2002) Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 90: 384-389.
36. Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117: 1162-1172. (Pubitemid 30228378)
37. Shibata M, Endo S, Inada K, Kuriki S, Harada M, et al. (1997) Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 17: 145-150. (Pubitemid 27148704)
38. Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, et al. (2004) Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 164: 665-677. (Pubitemid 38364680)